[go: up one dir, main page]

CZ279601B6 - Farmaceuticky účinné adiční soli s kyselinami odvozené od amidinohydrazonových derivátů, způsob je jich výroby, farmaceutické prostředky s jejich ob sahem a použití těchto sloučenin - Google Patents

Farmaceuticky účinné adiční soli s kyselinami odvozené od amidinohydrazonových derivátů, způsob je jich výroby, farmaceutické prostředky s jejich ob sahem a použití těchto sloučenin Download PDF

Info

Publication number
CZ279601B6
CZ279601B6 CS923152A CS315292A CZ279601B6 CZ 279601 B6 CZ279601 B6 CZ 279601B6 CS 923152 A CS923152 A CS 923152A CS 315292 A CS315292 A CS 315292A CZ 279601 B6 CZ279601 B6 CZ 279601B6
Authority
CZ
Czechia
Prior art keywords
acid
formula
acids
addition salts
derived
Prior art date
Application number
CS923152A
Other languages
Czech (cs)
English (en)
Inventor
Jaroslav Dr. Stanek
Jörg Dr. Frei
Giorgio Dr. Caravatti
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of CZ315292A3 publication Critical patent/CZ315292A3/cs
Publication of CZ279601B6 publication Critical patent/CZ279601B6/cs

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/18Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by doubly-bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C281/00Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
    • C07C281/16Compounds containing any of the groups, e.g. aminoguanidine
    • C07C281/18Compounds containing any of the groups, e.g. aminoguanidine the other nitrogen atom being further doubly-bound to a carbon atom, e.g. guanylhydrazones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/155Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06Antimalarials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C249/00Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C249/16Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton of hydrazones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/06One of the condensed rings being a six-membered aromatic ring the other ring being four-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Detergent Compositions (AREA)
  • Cereal-Derived Products (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cosmetics (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
CS923152A 1991-10-16 1992-10-16 Farmaceuticky účinné adiční soli s kyselinami odvozené od amidinohydrazonových derivátů, způsob je jich výroby, farmaceutické prostředky s jejich ob sahem a použití těchto sloučenin CZ279601B6 (cs)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH304191 1991-10-16

Publications (2)

Publication Number Publication Date
CZ315292A3 CZ315292A3 (en) 1993-05-12
CZ279601B6 true CZ279601B6 (cs) 1995-05-17

Family

ID=4247296

Family Applications (1)

Application Number Title Priority Date Filing Date
CS923152A CZ279601B6 (cs) 1991-10-16 1992-10-16 Farmaceuticky účinné adiční soli s kyselinami odvozené od amidinohydrazonových derivátů, způsob je jich výroby, farmaceutické prostředky s jejich ob sahem a použití těchto sloučenin

Country Status (24)

Country Link
EP (1) EP0538193B1 (hu)
JP (1) JP2788579B2 (hu)
KR (1) KR100265307B1 (hu)
AT (1) ATE145896T1 (hu)
AU (1) AU658931B2 (hu)
CA (1) CA2080545C (hu)
CY (1) CY2127B1 (hu)
CZ (1) CZ279601B6 (hu)
DE (1) DE59207617D1 (hu)
DK (1) DK0538193T3 (hu)
ES (1) ES2095444T3 (hu)
FI (1) FI112212B (hu)
GR (1) GR3021903T3 (hu)
HK (1) HK1005023A1 (hu)
HU (1) HU226954B1 (hu)
IL (1) IL103448A (hu)
MX (1) MX9205934A (hu)
NO (1) NO178108C (hu)
NZ (1) NZ244725A (hu)
RU (1) RU2081108C1 (hu)
SA (1) SA93130417B1 (hu)
SG (1) SG43185A1 (hu)
SK (1) SK279938B6 (hu)
ZA (1) ZA927957B (hu)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2103166B1 (es) * 1992-08-26 1998-04-01 Ciba Geigy Ag Procedimiento para la obtencion de amidinohidrazonas biciclicas.
JP3989543B2 (ja) * 1995-01-26 2007-10-10 ノバルティス・アクチエンゲゼルシャフト イミダゾール誘導体、その製造およびs−アデノシルメチオニンデカルボキシラーゼ(=samdc)阻害剤としてのその使用
EP1483231A1 (de) * 2002-03-04 2004-12-08 Boehringer Ingelheim Pharma GmbH & Co.KG Neue salmeterol-zimtsäuresalze, verfahren zu deren herstellung und deren verwendung als arzneimittel
GT200600316A (es) * 2005-07-20 2007-04-02 Sales de 4-metilo-n-(3-(4-metilo-imidazol-1-ilo)-5-trifluorometilo-fenilo)-3-(4-piridina-3-ilo-pirimidina-2-iloamino)- benzamida.
EP1884515A1 (en) 2006-07-31 2008-02-06 Laboratorios del Dr. Esteve S.A. Substituted indanyl sulfonamide compounds, their preparation and use as medicaments

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU645799B2 (en) * 1990-05-07 1994-01-27 Novartis Ag Hydrazones

Also Published As

Publication number Publication date
DE59207617D1 (de) 1997-01-16
CA2080545A1 (en) 1993-04-17
CA2080545C (en) 2005-11-29
HU226954B1 (en) 2010-03-29
SA93130417B1 (ar) 2005-11-12
IL103448A0 (en) 1993-03-15
EP0538193A3 (en) 1993-06-16
MX9205934A (es) 1993-04-01
AU658931B2 (en) 1995-05-04
HUT63149A (en) 1993-07-28
IL103448A (en) 1998-01-04
FI924650A0 (fi) 1992-10-14
SG43185A1 (en) 1997-10-17
JP2788579B2 (ja) 1998-08-20
SK315292A3 (en) 1995-04-12
DK0538193T3 (da) 1996-12-23
EP0538193A2 (de) 1993-04-21
EP0538193B1 (de) 1996-12-04
CZ315292A3 (en) 1993-05-12
FI112212B (fi) 2003-11-14
HU9203234D0 (en) 1992-12-28
ES2095444T3 (es) 1997-02-16
KR930007896A (ko) 1993-05-20
NO178108B (no) 1995-10-16
HK1005023A1 (en) 1998-12-18
CY2127B1 (en) 2002-06-21
KR100265307B1 (ko) 2000-09-15
ZA927957B (en) 1993-04-26
ATE145896T1 (de) 1996-12-15
GR3021903T3 (en) 1997-03-31
NO924001D0 (no) 1992-10-15
JPH05239011A (ja) 1993-09-17
AU2704092A (en) 1993-04-22
NO178108C (no) 1996-01-24
NO924001L (no) 1993-04-19
FI924650A (fi) 1993-04-17
SK279938B6 (sk) 1999-06-11
NZ244725A (en) 1995-05-26
RU2081108C1 (ru) 1997-06-10

Similar Documents

Publication Publication Date Title
US5461076A (en) Hydrazones
JP2664241B2 (ja) アリールヒドラゾン
US4968804A (en) Bipyridine compounds
JP3780004B2 (ja) 置換されたベンゾイルグアニジン、それらの製法、医薬または診断薬としてのそれらの使用およびそれらを含有する医薬
PL135749B1 (en) Method of obtaining novel imidazolilophenylamidines
EP0302603A1 (en) Dopamine-beta-hydroxylase inhibitors
CZ279601B6 (cs) Farmaceuticky účinné adiční soli s kyselinami odvozené od amidinohydrazonových derivátů, způsob je jich výroby, farmaceutické prostředky s jejich ob sahem a použití těchto sloučenin
US3742023A (en) Novel 1-substituted phenoxy-2-hydroxy-3-isopropylamino-propanes
RU2066311C1 (ru) Амидиногидразонпроизводные или их кислотно-аддитивные соли и средство, обладающее ингибирующим действием на фермент samdc
JPH06234727A (ja) 置換されたベンゾイルグアニジン、それらの製法、医薬または診断剤としてのそれらの使用およびそれらを含有する医薬
CZ419291A3 (en) Benzene derivatives, process of their preparation and pharmaceutical compositions in which said derivatives are comprised
US5238941A (en) Arylhydrazones and pharmaceutical compositions thereof
EP0221778A2 (en) Dopamine-beta-hydroxylase inhibitors
US4882348A (en) 2-(aminoalkylthio)imidazoles as dopamine-β-hydroxylase inhibitors
CZ291538B6 (cs) Antiarytmické a kardioprotektivní substituované indenoylguanidiny, způsob jejich přípravy a farmaceutické prostředky, které je obsahují
JPS6059230B2 (ja) 不整脈抑制性フエネチルピペリジン化合物
AU648377B2 (en) Bipyridyls
EP1047668B1 (en) Triazepinones, process for their preparation and their therapeutic application
US4912226A (en) Intermediate to dopamine-β-hydroxylase inhibitors
CZ220392A3 (en) Substituted 1-phenyl-1-benzoylamino-5-aminopentanes, their preparation and use

Legal Events

Date Code Title Description
IF00 In force as of 2000-06-30 in czech republic
MM4A Patent lapsed due to non-payment of fee

Effective date: 20101016